Back
NovaBay Pharmaceuticals Stock Price Chart
I love this overnight trade happening Thursday
Access my free presentation on these overnight trades right here
Sell
14
NBY
NovaBay Pharmaceuticals
Last Price:
0.08
Seasonality Move:
-8.08%
7 Day Trial
ALL ACCESS PASS
$
7
Earn Your Weekly "Paycheck" with Chuck's Secret Income Strategy!
Act now for your path to extra income!- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing slight buying pressure.
NovaBay Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.08 | Buy |
| 20-day SMA: | 0.09 | Sell |
| 50-day SMA: | 0.12 | Sell |
| 200-day SMA: | 0.33 | Sell |
| 8-day EMA: | 0.08 | Buy |
| 20-day EMA: | 0.09 | Sell |
| 50-day EMA: | 0.12 | Sell |
| 200-day EMA: | 0.56 | Sell |
NovaBay Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 35.62 | Sell |
| Chaikin Money Flow: | 746512 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
NovaBay Pharmaceuticals Technical Analysis
| Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for NovaBay Pharmaceuticals Stock
Is NovaBay Pharmaceuticals Stock a Buy?
- NovaBay Pharmaceuticals share price is 0.08 while NBY 8-day simple moving average is 0.08, which is a Buy signal.
- The stock price of NBY is 0.08 while NovaBay Pharmaceuticals 20-day SMA is 0.09, which makes it a Sell.
- NovaBay Pharmaceuticals 50-day simple moving average is 0.12 while NBY share price is 0.08, making it a Sell technically.
- NBY stock price is 0.08 and NovaBay Pharmaceuticals 200-day simple moving average is 0.33, creating a Sell signal.
NBY Technical Analysis vs Fundamental Analysis
Sell
14
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy or a Sell?
-
NovaBay Pharmaceuticals stock is rated a Sell
The current NovaBay Pharmaceuticals [NBY] share price is $0.08. The Score for NBY is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
NovaBay Pharmaceuticals Stock Info
Market Cap:
2.43M
Price in USD:
0.08
Share Volume:
1.15M
NovaBay Pharmaceuticals 52-Week Range
52-Week High:
1.28
52-Week Low:
0.07
Sell
14
NovaBay Pharmaceuticals (NBY)
is a Sell
NovaBay Pharmaceuticals Share Price Forecast
-
What is the NovaBay Pharmaceuticals stock price today?
The NovaBay Pharmaceuticals stock price is 0.08 USD today. -
Will NBY stock go up or go down?
NovaBay Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is NovaBay Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, NovaBay Pharmaceuticals is overvalued.
Is NovaBay Pharmaceuticals Stock a Buy?
- NovaBay Pharmaceuticals share price is 0.08 while NBY 8-day exponential moving average is 0.08, which is a Buy signal.
- The stock price of NBY is 0.08 while NovaBay Pharmaceuticals 20-day EMA is 0.09, which makes it a Sell.
- NovaBay Pharmaceuticals 50-day exponential moving average is 0.12 while NBY share price is 0.08, making it a Sell technically.
- NBY stock price is 0.08 and NovaBay Pharmaceuticals 200-day simple moving average is 0.56, creating a Sell signal.
Fundamental Analysis of NovaBay Pharmaceuticals
Is NovaBay Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.35 per share, an increase next quarter of $0.04 per share, an increase this year of $2.04 per share, and an increase next year of $0.30 per share.
Technical Analysis of NovaBay Pharmaceuticals
Should I short NovaBay Pharmaceuticals stock?
- NBY Moving Average Covergence Divergence (MACD) indicator is -0.01, suggesting NovaBay Pharmaceuticals is a Sell
- NovaBay Pharmaceuticals Relative Strength Index (RSI) is 35.62, which suggest NovaBay Pharmaceuticals is oversold
- The Bollinger Bands (25) for NovaBay Pharmaceuticals is ( - ), which suggest NovaBay Pharmaceuticals is a Buy
- The Bollinger Bands (100) for NovaBay Pharmaceuticals is ( - ), which suggest NovaBay Pharmaceuticals is a Buy
* NovaBay Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.